•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.Sharp Therapeutics Announces Non-Brokered Private Placement and Provides Operational Update
Sharp Business Systems Expanded Thousands of Accounts with ZoomInfo
Is Accelerant Stock a Buy After Its Sharp Pullback and Nearly 16X P/E?
Is VSXY Stock Still Worth Buying After Its Sharp Rally in 2026
Sharp Therapeutics Announces Filing of Amended and Restated Management Information Circular and New Annual Meeting Date
Roze AI Pursues U.S. Direct Listing Despite Sharp Revenue Drop
Rocket Lab's NASA Win Tests Key Support After Sharp Pullback
How to Approach Abbott Stock Following Its Sharp YTD Decline?
The Fed Just Triggered a Sharp Tech-Sector Sell-Off: Here Is the 1 Dirt-Cheap Financial Disruptor I'm Buying Hand Over Fist
Norway's Kongsberg Gruppen Targets Sharp Rise in Revenue
Sharp Therapeutics Presents New Preclinical Data Supporting Novel Small-Molecule Therapeutic Approach for Niemann-Pick Disease Type C
Sociedad Química y Minera de Chile: Q1 Results, Fundamentals Justify Sharp Upgrade
Starz Entertainment: Even After The Sharp Rally, Upside Remains
United Parks Stock Tumbles After Earnings Miss, Sharp Attendance Decline
Virtuix Maps VR Growth Push as CEO Addresses Sharp Stock Slide
Semiconductor Index Rally Stays on Course, but Signs Point to a Sharp Retracement
Nvidia Stock Faces a Battle to Reclaim Key $200 Level After Sharp Drop
Navitas Is One Misstep Away From A Sharp Re-Rating
Sharp Therapeutics Corp. Announces Fourth Quarter 2025 Results, Closing of Convertible Note Offering and Adoption of Semi-Annual Reporting
Short Interest in Sharp Corp. (OTCMKTS:SHCAY) Decreases By 57.2%